• Spinraza (nusinersen)

  NICE Opposes Adding SMA Treatment, Spinraza, to UK Public Health System

  Posted by sma-news-today-moderator on August 17, 2018 at 1:07 pm

  NICE, the U.K. agency that decides on therapies in the public health system of England and Wales, is recommending against Spinraza (nusinersen) for SMA.

  Click here to find out why.

  What are your thoughts on this news? What do you wish representatives from NICE better understood about Spinraza and SMA?

  sma-news-today-moderator replied 5 years, 8 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply